Transcept announces layoffs

Share this article:

Transcept Pharmaceuticals—known for its sleep drug Intermezzo—is cutting 43% of its workforce.

The company announced Tuesday that six employees will be laid off between now and early 2014, leaving a staff of eight.

The layoffs are part of a larger restructuring that includes reorganizing its board of directors.

The company's lead pipeline product, TO-2070, is for acute migraines.

Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Penn and Teller give take on vaccines

The Las Vegas twosome give the anti-vaccination movement their signature treatment.

GSK allegations build in Jordan and Lebanon

GlaxoSmithKline says it is investigating allegations of employee misconduct. The company said in a statement that the allegations have numbers "very similar to those reported by other companies in our sector."

Generic Celebrex is coming

Pfizer and Teva's settlement puts generic Celebrex on the market by December.